Purine derivatives for use as adenosin A-2A receptor agonists

Details for Australian Patent Application No. 2009233613 (hide)

Owner Novartis AG

Inventors Taylor, Roger John; Fairhurst, Robin Alec; Singh, Paul

Agent Davies Collison Cave

Pub. Number AU-A-2009233613

Parent 2005298878

Filing date 30 October 2009

Wipo publication date 26 November 2009

International Classifications

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 473/32 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 473/40 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

19 November 2009 Complete Application Filed

26 November 2009 Application Open to Public Inspection

  Published as AU-A-2009233613

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009233614-Processing cap assembly for isolating contents of a container

2009233612-IV catheter